Abstract
Binding of platelet-activating factor (PAF) to a specific high-affinity membrane receptor has been demonstrated in numerous cell types, but very little is known about the molecular nature of this receptor. The receptor from rabbit platelets was solubilized using CHAPS, digitonin, octyl glucoside, Nonidet P-40 or sodium cholate, either with pre-bound [3H]PAF or in the absence of ligand. We have been able to demonstrate for the first time that the receptor solubilized with CHAPS, in the absence of ligand, could retain its binding activity. It migrated as a high molecular mass complex (greater than 350 kDa) on a Bio-Gel A-0.5 m gel filtration column. Binding to solubilized receptor rapidly reached an equilibrium at room temperature, but was much slower at 0 degrees C. Scatchard plots were used to calculate the number (approx. 100 per cell) and the affinity (Kd 2.5 +/- 1.4 nM) of the solubilized receptors. These values were comparable with those obtained from whole-cell binding experiments. Competition by PAF antagonists also verified that the assay was measuring PAF receptor binding activity. The presence of a protein in the receptor complex was demonstrated by heat and trypsin inactivation of binding activity. Trypsin had no effect on binding of PAF to whole cells, but was able to decrease binding activity in solubilized receptor preparations. Attempts to demonstrate the involvement of a glycoprotein by use of various lectin columns proved unsuccessful. The latter results are consistent with findings suggesting that the binding site of the PAF receptor may not be exposed at the cell surface.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blank M. L., Cress E. A., Lee T. C., Malone B., Surles J. R., Piantadosi C., Hajdu J., Snyder F. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses. Res Commun Chem Pathol Pharmacol. 1982 Oct;38(1):3–20. [PubMed] [Google Scholar]
- Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
- Chau L. Y., Jii Y. J. Characterization of 3H-labelled platelet activating factor receptor complex solubilized from rabbit platelet membranes. Biochim Biophys Acta. 1988 Jun 30;970(2):103–112. doi: 10.1016/0167-4889(88)90168-1. [DOI] [PubMed] [Google Scholar]
- Chau L. Y., Tsai Y. M., Cheng J. R. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes. Biochem Biophys Res Commun. 1989 Jun 30;161(3):1070–1076. doi: 10.1016/0006-291x(89)91352-1. [DOI] [PubMed] [Google Scholar]
- Duronio V., Reany A., Wong S., Bigras C., Salari H. Characterization of platelet-activating factor receptors in porcine platelets. Can J Physiol Pharmacol. 1990 Dec;68(12):1514–1519. doi: 10.1139/y90-230. [DOI] [PubMed] [Google Scholar]
- Hanahan D. J. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem. 1986;55:483–509. doi: 10.1146/annurev.bi.55.070186.002411. [DOI] [PubMed] [Google Scholar]
- Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 1991 Jan 24;349(6307):342–346. doi: 10.1038/349342a0. [DOI] [PubMed] [Google Scholar]
- Hwang S. B. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem. 1988 Mar 5;263(7):3225–3233. [PubMed] [Google Scholar]
- Hwang S. B., Lam M. H., Pong S. S. Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. J Biol Chem. 1986 Jan 15;261(2):532–537. [PubMed] [Google Scholar]
- Hwang S. B., Lee C. S., Cheah M. J., Shen T. Y. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry. 1983 Sep 27;22(20):4756–4763. doi: 10.1021/bi00289a022. [DOI] [PubMed] [Google Scholar]
- Kloprogge E., Akkerman J. W. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J. 1984 Nov 1;223(3):901–909. doi: 10.1042/bj2230901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Marquis O., Robaut C., Cavero I. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes. J Pharmacol Exp Ther. 1988 Feb;244(2):709–715. [PubMed] [Google Scholar]
- Nishihira J., Ishibashi T., Imai Y., Muramatsu T. Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. Tohoku J Exp Med. 1985 Oct;147(2):145–152. doi: 10.1620/tjem.147.145. [DOI] [PubMed] [Google Scholar]
- O'Flaherty J. T., Surles J. R., Redman J., Jacobson D., Piantadosi C., Wykle R. L. Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest. 1986 Aug;78(2):381–388. doi: 10.1172/JCI112588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pinckard R. N., Farr R. S., Hanahan D. J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol. 1979 Oct;123(4):1847–1857. [PubMed] [Google Scholar]
- Pretolani M., Ferrer-Lopez P., Vargaftig B. B. From anti-asthma drugs to PAF-acether antagonism and back. Present status. Biochem Pharmacol. 1989 May 1;38(9):1373–1384. doi: 10.1016/0006-2952(89)90175-5. [DOI] [PubMed] [Google Scholar]
- Salari H., Demos M., Wong A. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat. Circ Shock. 1990 Nov;32(3):189–207. [PubMed] [Google Scholar]
- Salari H., Duronio V., Howard S. L., Demos M., Jones K., Reany A., Hudson A. T., Pelech S. L. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets. FEBS Lett. 1990 Apr 9;263(1):104–108. doi: 10.1016/0014-5793(90)80715-u. [DOI] [PubMed] [Google Scholar]
- Tahraoui L., Floch A., Mondot S., Cavero I. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Mol Pharmacol. 1988 Aug;34(2):145–151. [PubMed] [Google Scholar]
- Vallari D. S., Austinhirst R., Snyder F. Development of specific functionally active receptors for platelet-activating factor in HL-60 cells following granulocytic differentiation. J Biol Chem. 1990 Mar 15;265(8):4261–4265. [PubMed] [Google Scholar]
- Valone F. H., Coles E., Reinhold V. R., Goetzl E. J. Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol. 1982 Oct;129(4):1637–1641. [PubMed] [Google Scholar]
- Wykle R. L., Miller C. H., Lewis J. C., Schmitt J. D., Smith J. A., Surles J. R., Piantadosi C., O'Flaherty J. T. Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. Biochem Biophys Res Commun. 1981 Jun;100(4):1651–1658. doi: 10.1016/0006-291x(81)90708-7. [DOI] [PubMed] [Google Scholar]